>Positive normalisation in business trends - For Q3 and for nine months, Eurazeo reported AUM of € 35.5bn, up +7% y-o-y and +1% on the quarter, with € 10.3bn on a proprietary basis (-4% for the year).AuM generating fees from third parties amounted to € 18.6bn, up 12%. It was boosted by inflows of € 3.0bn, up 76% on the year (the increase came to 63% in H1, so an acceleration).In terms of asset rotation, the group divested € 0.8bn of funds from its balan...
>Normalisation positive de l’activité - Au titre de son T3 et de ses 9 mois, Eurazeo publie des AUM de 35.5 Md€, en hausse de 7% sur l’année et de 1% sur le trimestre, dont 10.3 Md€ pour compte propre (-4% sur l’année).Les actifs sous gestion générant des commissions de tiers se montent à 18.6 Md€, en hausse de 12%. Ils sont portés par une collecte de 3.0 Md€, en hausse de 76% sur l’année (la hausse était de 63% au S1, en accélération donc).Au niveau de...
A director at Eurazeo sold 3,939 shares at 75.000EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
>H1 marks gradual acceleration - Eurazeo published this morning a net asset value per share of € 106.9 for H1 2024, down 2% compared with end-2023 (-4% on the total value, but -2% in euros per share with the impact of the SBB). The value of companies remaining in the portfolio fell by 0.6%, with the remainder (-3.7%) mainly due to changes in the business scope (mainly DORC). We are assuming a valuation for third-party AM of € 1.6bn, i.e. € 21.6 per share, giving a tot...
>Un S1 en accélération progressive - Eurazeo publie ce matin un ANR Bilan/action de 106.9 € au Titre du S1 2024 en baisse de 2% par rapport à fin 2023 (-4% sur la valeur totale, mais -2% en euros par action avec l’impact du SBB). La valeur des sociétés restées en portefeuille a, elle, baissé de 0.6%, le reste (-3.7%) étant surtout un effet périmètre (DORC principalement). Nous retenons une valorisation de l’AM pour compte de tiers de 1.6 Md€, soit 21.6 € par action et...
We have tactically downgraded the energy sector from Overweight to Neutral (excl. oil services on which we are maintaining our Overweight rating) and dropped Shell Plc from our Large Caps list. The IEA report has accelerated the downswing for the energy sector, which could continue in the days ahead. June will be a better month to come back to the sector. - ...
>Un T1 soft, sans surprise, pas nécessairement à l’image du reste de l’année. - Pour rappel, lors des publications trimestrielles, Eurazeo n’évalue pas son portefeuille non coté et ne détient pas de sociétés cotées. Ainsi, sans surprise, Eurazeo publie un ANR bilan de 109.9 €/action au titre de son T1 2024, très proche du niveau de fin 2023 à 109.6 €.Les AUM globaux ressortent à 34.8 Md€, en hausse de 8% sur 12 mois et stables sur le trimestre. Les AUM pour compt...
>A soft first quarter, but not necessarily a reflection of the rest of the year - To recap, in quarterly releases, Eurazeo does not evaluate its unlisted portfolio and does not hold any listed firms. As such, unsurprisingly, Eurazeo reported a balance sheet NAV of € 109.9 a share for Q1 2024, very close to the level at end-2023 at € 109.6.Overall AuM came in at € 34.8bn, up 8% over 12 months and stable on the quarter. AuM for third parties thus came in 9% higher ...
Nous dégradons tactiquement à Neutre le secteur de l’énergie (hors Services Pétroliers sur lesquels nous conservons une opinion Surperformance) et faisons sortir Shell plc de notre liste Large Caps. Le rapport AIE a accéléré la baisse du secteur énergie, qui pourrait se poursuivre dans les jours qui viennent. Juin sera un meilleur mois pour revenir sur le secteur. - ...
• Q1 24 AuM at EUR 34.8bn, slightly down QoQ• No significant fundraising closings and an uptick in distributions resulting in subdued growth which should accelerate during the rest of year (calendar effect)• Nonetheless, some investors may be surprised by this temporary hiccup especially as there is no quarterly valuation for the portfolio• Our investment case still stands, which is based on an expected recovery in exits in the latter part of the year which should be at decent prices and should ...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
>2023 sans surprise - Eurazeo a publié ce matin un ANR bilan/action de 109.6 € au titre de 2023, en hausse de 9% vs fin 2022 (100.6 €). Nous retenons une valorisation de l’AM pour compte de tiers de 1.6 Md€, soit 21.1 € par action, soit un ANR total de 130.7 €/action (vs 127.1€ fin 2022). Les AUM globaux se portent à 35 Md€, en hausse de 9% sur 12 mois. Les AUM pour compte de tiers, à hauteur de 24.2 Md€ sont en hausse de 12% sur 12 mois, sur une collecte de 3.5 ...
>2023 unsurprising - Eurazeo this morning reported a balance sheet NAV per share of € 109.6 for 2023, up 9% on end-2022 (€ 100.6). We note a valuation for third-party AM of € 1.6bn, or € 21.1 per share, i.e. a total NAV of € 130.7 per share (vs € 127.1 at end-2022). Overall AuM came to € 35bn, up 9% over 12 months. AuM for third parties, at € 24.2bn, posted growth of 12% over 12 months, with inflows of € 3.5bn, including € 0.9m for private clients in a less favou...
• AuM at EUR 35bn, up 9% YoY. Management fees at EUR 398m (+9%) with FRE at EUR 138m (+22%) and an improving FRE margin (34.8% vs. 31% FY22)• Proposed dividend of EUR 2.42 p/s, up 10%• Exits subdued in 2023 but at 23% uplift compared to last NAV• We estimate today's NAV at EUR 126.4 p/s, implying a still elevated discount of 39%. Our TP is slightly raised to EUR 97.0 (vs. EUR 93.0 before)- BUY maintained
>End of a hybrid model - The CMD acknowledges, in our view, the realization that, from a stock market perspective, hybrid models combining a very large balance sheet, with an asset management activity on behalf of third parties, are very poorly valued. The group is therefore acting accordingly, by choosing to shrink its balance sheet (which is generally subject to a discount, more or less significant depending on the period, but almost never to a premium). In contrast...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.